GlassScriptPhysician profile
Aaron D Stewart
NPI 1124024690
$1,197.23
in general payments reported to CMS, 2019-2025
23 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.13 · 2020: $13.94 · 2022: $191 · 2023: $437 · 2024: $331 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $155.30 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $125.64 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Aspira Women'S Health INC | $121.64 | 2022-2023 | Ova1 |
| Astellas Pharma US INC | $110.92 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $97.36 | 2023-2024 | Aptima, Acessa Provu System, Novasure |
| Sumitomo Pharma America, INC. | $91.36 | 2023-2025 | Myfembree |
| Channel Medsystems, INC. | $68.64 | 2023 | |
| Mayne Pharma Commercial LLC | $63.91 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $44.73 | 2020-2023 | Gardasil 9 |
| Biogen, INC. | $42.57 | 2024-2025 | Zurzuvae |
| Meditrina | $35.60 | 2023-2024 | |
| Pfizer INC. | $34.02 | 2022-2023 | |
| Organon LLC | $30.49 | 2023-2025 | Nexplanon |
| Smith+Nephew, INC. | $28.52 | 2025 | Pico 7, Pico 14 |
| Vertex Pharmaceuticals Incorporated | $28.11 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.13 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.30 | 2022 | |
| Shield Therapeutics INC | $16.13 | 2025 | |
| Exact Sciences Corporation | $15.34 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $13.58 | 2019 | |
| Duchesnay USA Incorporated | $13.42 | 2019 | |
| Agile Therapeutics, INC. | $13.28 | 2022 | |
| Ascend Therapeutics US, LLC | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.